Cargando…

c-Met and EPHA7 Receptor Tyrosine Kinases Are Related to Prognosis in Clear Cell Renal Cell Carcinoma: Focusing on the Association with Myoferlin Expression

SIMPLE SUMMARY: Receptor tyrosine kinases are essential for the development, growth, and progression of clear cell renal cell carcinoma (ccRCC). Targeted therapies using receptor tyrosine kinase inhibitors are widely used in ccRCC treatment. Myoferlin is a well-known protein that regulates various r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Minsun, Lee, Seokhyeon, Moon, Kyung Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870418/ https://www.ncbi.nlm.nih.gov/pubmed/35205843 http://dx.doi.org/10.3390/cancers14041095

Ejemplares similares

Loss of aquaporin-1 expression is associated with worse clinical outcomes in clear cell renal cell carcinoma: an immunohistochemical study
por: Lee, Seokhyeon, et al.
Publicado: (2023)

Prognostic role of myoferlin expression in patients with clear cell renal cell carcinoma
por: Song, Dae Hyun, et al.
Publicado: (2017)

Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma
por: An, Hyo Jung, et al.
Publicado: (2019)

The Prognostic Significance of Protein Expression of CASZ1 in Clear Cell Renal Cell Carcinoma
por: Kim, Bohyun, et al.
Publicado: (2019)

High expression of FER tyrosine kinase predicts poor prognosis in clear cell renal cell carcinoma
por: WEI, CAN, et al.
Publicado: (2013)

The prognostic significance of nuclear expression of PHF2 and C/EBPα in clear cell renal cell carcinoma with consideration of adipogenic metabolic evolution
por: Park, Jeong Hwan, et al.
Publicado: (2017)

Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor
por: Zhang, Hailiang, et al.
Publicado: (2023)

The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells
por: Shin, Won‐Sik, et al.
Publicado: (2020)

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size
por: Zapata-Mercado, Elmer, et al.
Publicado: (2022)

MET Inhibition in Clear Cell Renal Cell Carcinoma
por: Xie, Zuoquan, et al.
Publicado: (2016)

Progranulin and the receptor tyrosine kinase EphA2, partners in crime?
por: Chitramuthu, Babykumari, et al.
Publicado: (2016)

Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer
por: Andretta, Elena, et al.
Publicado: (2017)

Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma
por: Gustafsson, Anna, et al.
Publicado: (2009)

Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas
por: Zhang, Qing, et al.
Publicado: (2019)

Molecular mechanisms of resistance to tyrosine kinase inhibitor in clear cell renal cell carcinoma
por: Sekino, Yohei, et al.
Publicado: (2022)

Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: Prognosis for Clear Cell Renal Cell Carcinoma
por: Li, Qinke, et al.
Publicado: (2020)

Tyrosine kinase signaling-independent MET-targeting with CAR-T cells
por: Qin, Anna, et al.
Publicado: (2023)

Prognostic Implication of pAMPK Immunohistochemical Staining by Subcellular Location and Its Association with SMAD Protein Expression in Clear Cell Renal Cell Carcinoma
por: Jung, Minsun, et al.
Publicado: (2019)

Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells
por: Rademaker, Gilles, et al.
Publicado: (2022)

Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer
por: Yao, Yu, et al.
Publicado: (2023)

Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in  Clear - Cell Renal Cell Carcinoma (ccRCC)
por: Bielecka, Zofia F., et al.
Publicado: (2013)

Receptor tyrosine kinase EphA7 is required for interneuron connectivity at specific subcellular compartments of granule cells
por: Beuter, Simone, et al.
Publicado: (2016)

Helicobacter Pylori Targets the EPHA2 Receptor Tyrosine Kinase in Gastric Cells Modulating Key Cellular Functions
por: Leite, Marina, et al.
Publicado: (2020)

Mutation of the EPHA2 Tyrosine-Kinase Domain Dysregulates Cell Pattern Formation and Cytoskeletal Gene Expression in the Lens
por: Zhou, Yuefang, et al.
Publicado: (2021)

Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib
por: Vasudev, Naveen S., et al.
Publicado: (2011)

Myoferlin, a Membrane Protein with Emerging Oncogenic Roles
por: Dong, Yimin, et al.
Publicado: (2019)

Loss of Myoferlin Redirects Breast Cancer Cell Motility towards Collective Migration
por: Volakis, Leonithas I., et al.
Publicado: (2014)

A Novel Occulta-Type Spina Bifida Mediated by Murine Double Heterozygotes EphA2 and EphA4 Receptor Tyrosine Kinases
por: Abdullah, Nor Linda, et al.
Publicado: (2017)

Targeting Host Tyrosine Kinase Receptor EPHA2 Signaling Affects Uropathogen Infection in Human Bladder Epithelial Cells
por: Prakash, Prema S., et al.
Publicado: (2022)

Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma
por: Lee, Cheol, et al.
Publicado: (2017)

EphA1 receptor tyrosine kinase is localized to the nucleus in rhabdomyosarcoma from multiple species
por: LaCombe, Ronnie, et al.
Publicado: (2022)

Acquired Resistance Mechanism for MET Tyrosine Kinase Inhibitor
por: Fujino, Toshio, et al.
Publicado: (2021)

AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis
por: Choi, Yun Jung, et al.
Publicado: (2019)

Myoferlin expression in non-small cell lung cancer: Prognostic role and correlation with VEGFR-2 expression
por: SONG, DAE HYUN, et al.
Publicado: (2016)

Correlation between myoferlin expression and lymph node metastasis in papillary thyroid carcinoma
por: Na, Ji Min, et al.
Publicado: (2022)

Myoferlin Is a Yet Unknown Interactor of the Mitochondrial Dynamics’ Machinery in Pancreas Cancer Cells
por: Anania, Sandy, et al.
Publicado: (2020)

Connexin43 is associated with the progression of clear cell renal carcinoma and is regulated by tangeretin to sygergize with tyrosine kinase inhibitors
por: Lai, Yongchang, et al.
Publicado: (2023)

Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
por: Chang, Q, et al.
Publicado: (2008)

Dimerization of the EphA1 Receptor Tyrosine Kinase Transmembrane Domain: Insights into the Mechanism of Receptor Activation
por: Chavent, Matthieu, et al.
Publicado: (2014)

Receptor Tyrosine Kinase EphA5 Is a Functional Molecular Target in Human Lung Cancer
por: Staquicini, Fernanda I., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7o2b5adnkgmc4r4knuln34ub6a